Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Regeneron Study

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Patients with Moderate-to-Serve Asthma (R668-AS-1903)

woman trying to catch her breath
Age: 18-55 years old
Sex at Birth: All
Type: Translational Study
Condition: Moderate to Severe Asthma
Healthy Participants: Yes
Location: UH Cleveland Medical Center

Learn More About This Research Study

For more information, please contact Katie Northcutt, RN, BSN at 216-286-0220 or complete the online form below.

Study Purpose

The purpose of this study is to determine the safety and effectiveness of a study drug called dupilumab, on exercise capacity in people who have moderate-to-severe asthma.

Who Can Participate

Participants between 18-55 years old diagnosed with asthma may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot